A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Warfarin in Healthy Male and Female Adults.

Trial Profile

A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Warfarin in Healthy Male and Female Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2012

At a glance

  • Drugs Sucroferric oxyhydroxide (Primary) ; Warfarin
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 Feb 2012 Actual end date (February 2012) added as reported by ClinicalTrials.gov.
    • 15 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top